Pfizer-BioNTech vaccine neutralizes Brazil COVID-19 variant


Pfizer-BioNTech vaccine neutralizes Brazil COVID-19 variant

Pfizer Inc DOWN 0.12% AT 34.35

The Pfizer coronavirus vaccine is able to neutralize a rapidly spreading virus variant from Brazil, according to a new laboratory study.

Researchers developed an engineered version of the COVID-19 mutation and found that blood samples taken from people who received the vaccine were able to neutralize the variant, according to the study published in the New England Journal of Medicine on Monday.

The scientists from Pfizer PFE, BioNTech BNTX, and the University of Texas Medical Branch said the vaccine was roughly as effective against the Brazilian variant as other less contagious virus versions from last year.

Earlier studies found that the U.K. and South Africa COVID-19 variants were also neutralized by the Pfizer vaccine.

But the South African variant, according to studies, may diminish protective antibodies induced by the vaccine.

On technical fronts Pfizer Inc RSI stood at 44.92 and currently stock is trading below 50 days MA and above 5 & 20 days Moving Averages. So, SELL position can be taken with following target and stoploss.

TRADE SIGNAL -: Pfizer Inc – SELL: 34.32, TARGET: 33.91, STOP LOSS: 34.86

About Author

Related posts

Leave a Reply